Area of research
Genetics · Cellular and Molecular Neuroscience
Research interest
Research interests include Genetic Associations and Epidemiology, Neurotransmitter Receptor Influence on Behavior, Schizophrenia research and treatment, and Tryptophan and brain disorders.
Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations
Uncovering the genetic architecture of broad antisocial behavior through a genome-wide association study meta-analysis
A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts
Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders
Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics
Uncovering the Genetic Architecture of Broad Antisocial Behavior through a Genome-Wide Association Study Meta-analysis
Genome-wide association study identifies 48 common genetic variants associated with handedness
Shared genetic risk between eating disorder‐ and substance‐use‐related phenotypes: Evidence from genome‐wide association studies
Sex-Dependent Shared and Non-Shared Genetic Architecture Across Mood and Psychotic Disorders
Identifying Nootropic Drug Targets via Large-Scale Cognitive GWAS and Transcriptomics
Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways
The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways
Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence
Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
Age at first birth in women is genetically associated with increased risk of schizophrenia
Instability of personal human metabotype is linked to all-cause mortality
Trans-ancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders
The human metabolic profile reflects macro- and micronutrient intake distinctly according to fasting time
Multi-Trait Analysis of GWAS and Biological Insights Into Cognition: A Response to Hill (2018)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium
Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia
Large-Scale Cognitive GWAS Meta-Analysis Reveals Tissue-Specific Neural Expression and Potential Nootropic Drug Targets
Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics
GWAS meta-analysis (N=279,930) identifies new genes and functional links to intelligence
Ninety-nine independent genetic loci influencing general cognitive function include genes associated with brain health and structure (N = 280,360)